Background/Aim: Adiponectin, an adipocyte-derived protein, has been shown to exert
antidiabetic, anti-inflammatory, and antiatherosclerotic effects. Although recent reports show …

Adiponectin, a novel adipose-derived adipocytokine, has beneficial effects not only on
improvement of insulin sensitivity but also on mitigation of vascular damage. To evaluate …

Background Adiponectin, a peptide hormone secreted from adipocytes, exerts anti-diabetic,
anti-atherogenic, and anti-inflammatory properties. We aimed to determine the relationship …

Adiponectin is secreted specifically by adipose tissue. It was reported that the serum
adiponectin level was markedly increased in patients with end-stage renal disease and was …

Aims: Adiponectin seems to be an important modulator for metabolic and vascular diseases.
We aimed to measure plasma adiponectin levels in type 2 diabetic patients and investigate …

Background: Several studies have shown that type 1 diabetic patients have elevated total
levels of the adipocyte-derived adipocytokine adiponectin. However, adiponectin circulates …

Low serum adiponectin is associated with a high incidence of type 2 diabetes or coronary
artery disease in the general population. Paradoxically, serum adiponectin is elevated in …

Background. Adiponectin, an anti-inflammatory and insulin-sensitizing cytokine, has been
shown to reduce proteinuria and glomerulosclerosis in experimental models. We assessed …

Adiponectin is the adipokine associated with insulin sensitization, reducing liver
gluconeogenesis, and increasing fatty acid oxidation and glucose uptake. Adiponectin is …

Adiponectin has antidiabetic properties, and patients with obesity, diabetes, and insulin
resistance have low plasma adiponectin levels. However, although kidney disease is …